LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.23 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹1.46 Cr | ₹2.19 Cr |
What is the latest Contingent Liabilities ratio of LINCOLN PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.23 Cr |
Mar2023 | ₹0.23 Cr |
Mar2022 | ₹0.23 Cr |
Mar2021 | ₹1.46 Cr |
Mar2020 | ₹2.19 Cr |
How is Contingent Liabilities of LINCOLN PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.23 Cr | 0.00 | |
Mar2023 | ₹0.23 Cr | 0.00 | |
Mar2022 | ₹0.23 Cr | -84.22 | |
Mar2021 | ₹1.46 Cr | -33.21 | |
Mar2020 | ₹2.19 Cr | - |
Compare Contingent Liabilities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,569.8 Cr | -3.8% | 24.7% | 31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.8% |
24.7% |
31.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses